5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one

C21H23N5OS — CID 125055592

IUPAC5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one
SMILESCC[C@@H]1CSC2=N[C@@H](c3ccccn3)[C@H](c3ccc4c(c3)n(C)c(=O)n4C)N21
InChIInChI=1S/C21H23N5OS/c1-4-14-12-28-20-23-18(15-7-5-6-10-22-15)19(26(14)20)13-8-9-16-17(11-13)25(3)21(27)24(16)2/h5-11,14,18-19H,4,12H2,1-3H3/t14-,18+,19+/m1/s1
InChIKeyQULJPQLJGSUYKP-CCKFTAQKSA-N
MW393.52 g/mol
LogP3.25
Rot. Bonds3

About 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one

5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one (PubChem CID 125055592) has the molecular formula C21H23N5OS and a molecular weight of 393.52 g/mol. Its IUPAC name is 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one.

Molecular Properties

Compound Name5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one
PubChem CID125055592
Molecular FormulaC21H23N5OS
Molecular Weight393.52 g/mol
Exact Mass393.16
IUPAC Name5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one
SMILESCC[C@@H]1CSC2=N[C@@H](c3ccccn3)[C@H](c3ccc4c(c3)n(C)c(=O)n4C)N21
InChIInChI=1S/C21H23N5OS/c1-4-14-12-28-20-23-18(15-7-5-6-10-22-15)19(26(14)20)13-8-9-16-17(11-13)25(3)21(27)24(16)2/h5-11,14,18-19H,4,12H2,1-3H3/t14-,18+,19+/m1/s1
InChIKeyQULJPQLJGSUYKP-CCKFTAQKSA-N
XLogP3.25
TPSA55.42 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500393.52
LogP ≤ 53.25
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one?
The IUPAC name of 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one (CID 125055592) is 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one.
What is the SMILES notation for 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one?
The canonical SMILES for 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one is CC[C@@H]1CSC2=N[C@@H](c3ccccn3)[C@H](c3ccc4c(c3)n(C)c(=O)n4C)N21.
What is the InChIKey of 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one?
The InChIKey is QULJPQLJGSUYKP-CCKFTAQKSA-N. The full InChI is InChI=1S/C21H23N5OS/c1-4-14-12-28-20-23-18(15-7-5-6-10-22-15)19(26(14)20)13-8-9-16-17(11-13)25(3)21(27)24(16)2/h5-11,14,18-19H,4,12H2,1-3H3/t14-,18+,19+/m1/s1.
What are the key properties of 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one?
5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one has a molecular weight of 393.52 g/mol, XLogP of 3.25, 3 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(3R,5S,6R)-3-ethyl-6-pyridin-2-yl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-5-yl]-1,3-dimethylbenzimidazol-2-one is sourced from PubChem (CID 125055592), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).